Researchers reviewed evidence linking GLP-1 and GLP-1 receptor agonists to chronic pain modulation through gut microbial, ...

The diabetes drugs glucagon-like peptide-1 (GLP-1) receptor agonists and sodium glucose cotransporter 2 (SGLT-2) inhibitor ...

Glucagon-like peptide-1 (GLP-1) receptor agonist medications like semaglutide (Ozempic, Wegovy) may help slow biological aging by reducing chronic low-grade inflammation, which damages cells and ...

The GLP-1 hormone plays a pivotal role in regulating appetite and metabolic pace, signaling fullness after meals and supporting healthy glucose uptake. However, modern dietary patterns, chronic stress ...

Few new drugs have sparked as much interest and as many questions as GLP-1 agonists. Originally developed to manage blood sugar and support weight loss, these medications are currently being studied ...

THURSDAY, Jan. 22, 2026 (HealthDay News) — With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes. These ...

Studying mice, researchers at Toronto’s Sinai Health have found that semaglutide—the active ingredient in popular weight loss drugs that mimic the gut hormone GLP-1—acts directly on a subset of liver ...

Excess weight is a key modifiable risk factor for breast cancer. Glucagon-like peptide-1 receptor agonists (GLP-1) promote weight loss and improve metabolic health, but their effect on breast cancer ...